Feb 032019
 February 3, 2019  Posted by  Business, Healthcare

Mohana Ravindranath reports:

Companies are starting to sell “risk scores” to doctors, insurers and hospitals to identify patients at risk of opioid addiction or overdose, without patient consent and with little regulation of the kinds of personal information used to create the scores.

While the data collection is aimed at helping doctors make more informed decisions on prescribing opioids, it could also lead to blacklisting of some patients and keep them from getting the drugs they need, according to patient advocates.

Read more on Politico.

Sorry, the comment form is closed at this time.